Due to this, the FDA recently announced their decision to halt the mass production of compounded GLP-1 drugs by May 22, an important step towards protecting patients from the potential risks associated with unapproved versions of these drugs
Especially with active ingredients that can affect central signaling pathways and psychological factors, medical guidance, careful medical history taking, and regular follow-up monitoring are important
Byetta works in a few different ways to help manage type 2 diabetes
This is why long-term weight management often requires continued treatment
The Outsourcing Facilities Association and one major compounder, FarmaKeio, sued, arguing the delistings were rushed, sloppy and left patients scrambling